Please login to the form below

Not currently logged in

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Janssen builds on hepatitis C digital work with new patient programme

Partners with Bupa Home Healthcare for MyIncivo support programme

Janssen has joined forces with Bupa Home Healthcare for a new UK support programme for patients receiving its hepatitis C treatment Incivo (telaprevir).

The MyIncivo programme builds on the foundations laid by Janssen's UK digital marketing activities in the therapy area, which have been picking up pace since the September launch of its website.

MyIncivo aims to help chronic genotype-1 hep C patients to take care of themselves, stay motivated and in control while receiving Incivo in combination with peginterferon alfa and ribavirin.

Dr Peter Barnes, medical director at Janssen, said: “We recognise that treatment for hep C can be challenging and demands significant commitment from patients. We also recognise that the addition of telaprevir, one of a new class of medicines which directly targets the hep C virus, to the current standard treatment adds another element of complexity.

“That is why today we are launching this programme to support patients 24 hours a day, seven days a week for the full duration of their treatment if they are initiated on a telaprevir based treatment regimen.”

The personalised programme gives patients access to a case management platform and a MyIncivo nurse team, with information kept confidential between the patient, their hep C specialist healthcare professional and BUPA.

Dr Mehmood Syed, Medical Director at Bupa Home Healthcare stated: “Providing tailored support to get better health outcomes for the individual is at the heart of this programme. We want to empower patients so that they have more control over their health as well as provide them with dedicated medical expertise and support when they need it”.

Janssen said it hopes the programme will complement the care provided by a patient's hep C specialist healthcare professional and help with continuity of the patient's care and support.

It offers an SMS text dose reminder service to promote adherence; health coaching to motivate, promote adherence, and health and wellbeing; and advice and information on subjects like dealing with potential side-effects from an Incivo-based regimen.

Incivo was approved in Europe on September 20, 2011, and shortly before this Janssen launched

The website has the dual aim of raising general awareness of hepatitis C and also supporting patients, their families and carers. It includes an online UK Hepatitis C map and features (pre-moderated) user posts on a Wall section.

Janssen also has a dedicated YouTube channel for Help Every Person C, which includes a series of short patient videos and the following disease awareness video.

29th February 2012

From: Marketing


COVID-19 Updates and Daily News

Featured jobs


Add my company

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...